News
ReNeuron's latest press releases
ReNeuron announces Notice of AGM. 20/07/07
Guildford, UK, 20 July 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it has sent the notice of Annual General Meeting to shareholders. …
Read articlePreliminary Results for the Year Ended 31 March 2007. 27/06/07
Operational Highlights Application filed in November 2006 to commence initial clinical trial in the US with lead ReN001 stem cell therapy for stroke …
ReNeuron scientists generate pancreatic cell lines for treatment of diabetes. 22/06/07
Guildford, UK, 22 June 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it has taken a major step forward with its ReN002 diabetes …
Notification of Preliminary Results. 18/06/07
Guildford, UK, 15 June 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it will report its preliminary results for the year ending 31 March …
Millipore Corporation to promote ReNeuron's ReNcell® neural stem cell lines at leading international stem cell conference. 15/06/07
Guildford, UK, 15 June 2007: ReNeuron Group plc (LSE: RENE.L) today announces that US-based Millipore Corporation, the exclusive distributor of …
ReNeuron announces new data concerning its ReNcell® neural stem cell lines. 31/05/07
Guildford, UK, 31 May 2007: ReNeuron Group plc (LSE: RENE.L) today announces new data concerning its ReNcell®CX and ReNcell®VM neural cell …
ReNeuron announces collaboration to enhance its stem cell expansion technology. 18/05/07
Guildford, UK, 18 May 2007: ReNeuron Group plc (LSE: RENE.L) today announced that it has signed a Research Collaboration Agreement with King's College …
ReNeuron to present at key European healthcare investor conference. 11/05/07
Guildford, UK, 10 May 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it will be participating in the Acumen BioFin Rodman & Renshaw …
<< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page